Planet Labs Flaunts $815M Backlog, But Firm Contracted Value Is Shrinking

What happened

Planet Labs enters fiscal 2027's second half with $815 million in backlog and over $4 billion in satellite-services opportunities, as highlighted by Zacks, but the master report reveals that backlog has actually fallen from $900 million and RPO from $852 million earlier in the year. Q2 FY2027 delivered record revenue of $116.1 million (up 58% YoY) and positive adjusted EBITDA, driven by defense and intelligence at 70% of revenue, yet management guided Q3 down to $101-105 million with an expected EBITDA loss. The company has expanded capacity through new satellites and manufacturing, but capital intensity is rising: FY2027 capex guidance was raised to $100-115 million, and the company raised about $120 million via ATM equity issuance at $31.95 per share. While the demand story remains strong, especially in European sovereign programs like Sweden, the firm contracted value is not yet replenishing: RPO and backlog have declined sequentially, and government contracts carry termination-for-convenience risk. The stock at $16.02 already reflects much of the public-sector growth narrative, leaving limited margin of safety unless Q3 proves to be timing-related and RPO stabilizes without further dilution.

Implication

The next quarterly filing is pivotal: if Q3 revenue lands near the high end of $101-105 million and RPO/backlog stabilize, it would support the view that Q2's strength and the guide-down were timing-driven rather than demand-driven. Conversely, if Q3 misses and RPO declines again, the risk of a bear case (stock potentially toward $12) increases materially. Monitoring capex and ATM usage is critical; additional dilution or capex overruns would signal that growth is not self-funding. For entry, a price closer to $14 would offer better asymmetry, as the base-case implied value is $17 and the bull case is $22. Until then, a WAIT rating is appropriate, with re-assessment in 3-6 months.

Thesis delta

The Zacks article emphasizes backlog and opportunities, but does not mention that backlog and RPO have actually declined since January. The core thesis remains that Planet's sovereign-led growth is real but not yet translating into firm per-share value. No change to the overall WAIT rating, but the article's tone is overly optimistic relative to the underlying contract quality and capital discipline.